Last update 27 Feb 2026

CREPT-618

Overview

Basic Info

Drug Type
Nucleic acid drugs
Synonyms
CREPT-618
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsDigestive System DisordersOther Diseases
Active Indication
Advanced Malignant Solid NeoplasmMetastatic Solid TumorLocally Advanced Hepatocellular Carcinoma+ [1]
Inactive Indication-
Originator Organization
Heya (Beijing) Pharmaceutical Technology Co., Ltd
Active Organization
Heya (Beijing) Pharmaceutical Technology Co., LtdCancer Hospital Chinese Academy of Medical SciencesCancer Hospital Chinese Academy of Medical Sciences
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with CREPT-618
NCT07307053
/ Not yet recruitingPhase 1/2IIT
An Open-Label, Single-Arm, Phase I/II Platform Trial of Innovative Therapies and Technologies Primarily in Rare Tumors in China (PLATFORM2) in Patients With Advanced Solid Tumors
ChiCTR2600118701
/ RecruitingNot ApplicableIIT
A clinical study to evaluate the safety and preliminary pharmacodynamics characteristics of CREPT-618 in participants with hypertriglyceridemia
ChiCTR2500109564
/ Not yet recruitingNot ApplicableIIT
Clinical trial of CREPT-618 in the treatment of primary biliary cholangitis
100 Clinical Results associated with CREPT-618
Login to view more data
100 Translational Medicine associated with CREPT-618
Login to view more data
100 Patents (Medical) associated with CREPT-618
Login to view more data
100 Deals associated with CREPT-618
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2-
Cancer Hospital Chinese Academy of Medical SciencesCancer Hospital Chinese Academy of Medical Sciences
01 Jan 2026
Metastatic Solid TumorPhase 2-
Cancer Hospital Chinese Academy of Medical SciencesCancer Hospital Chinese Academy of Medical Sciences
01 Jan 2026
Locally Advanced Hepatocellular CarcinomaPhase 1
China
Cancer Hospital Chinese Academy of Medical SciencesCancer Hospital Chinese Academy of Medical Sciences
15 Sep 2025
Primary Biliary CholangitisClinical
China
Heya (Beijing) Pharmaceutical Technology Co., Ltd
30 Sep 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free